Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Clinical trial NCT03407144 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03407144
Sponsor: Merck Sharp & Dohme LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2018-04-09
Primary completion: 2026-11-06
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.